The Ministry of Health and Community Protection issued a decision specifying the procedures and controls for accompanying medical products with travelers coming to the country, with the aim of legalizing these practices.
According to Ministerial Resolution No. 99 of 2021, issued by the Minister of Health and Community Protection, Abdul Rahman Al Owais, regarding the procedures and controls for accompanying medical products with travelers coming to the UAE, without prejudice to any other procedures or controls stipulated in Ministerial Resolution No. 677 of 2019 where the first article stipulates From the decision to allow a person coming to the country to take narcotic drugs or psychotropic drugs for personal use, within the limits of a quantity that does not exceed the patient’s need for a maximum period of three months, provided that this is proven by a prescription or a medical report from the health facility in which he is being treated.
The second article of the decision stipulates that a person coming to the country is allowed to take other medical products not mentioned in Article (1) of this decision, including health care products and medical devices intended for personal use, provided that the amount accompanied does not exceed the patient’s need for a period of six months.
And the third article of the decision stipulates that in exceptional cases and with the approval of the Ministry of Health and Community Protection, a quantity of medicine may be brought for a period not exceeding the quantity specified in Article (2) of the decision, for the personal use of a citizen or resident who returns to the country after a treatment trip abroad, with the importance of submitting Request through the electronic smart system.
The fourth article of the decision stipulated that the inspectors of the Ministry of Health and Community Protection shall provide technical support to the employees in charge of monitoring passengers and goods at the country’s border crossings whenever they are requested to do so.
Decision No. (677) of 2019 regarding the procedures and controls for taking narcotic drugs or monitoring with travelers, specified narcotic drugs (N-narcotic) and controlled drugs (CD) pharmaceutical products that contain any of the active substances listed in the table of the International Narcotics Control Board ( INCD Numbers (1, 2, 3 and 4) contained in the International Convention on Narcotic Substances 1961 as amended by the 1972 Protocol, and tables of the International Narcotics Control Board (INCD) Numbers (1, 2, 3 and 4) contained in the International Convention on Psychotropic Substances, and Tables Numbers (1, 2, 3 and 4 and 5, 6, 7 and 8) contained in Federal Law No. 14 of 1995 and its amendments.
To obtain permission, a set of documents in Arabic or English must be submitted, which is a medical report from the health facility in which the patient is treated, documented by the health authority in the country in which he received treatment, or from the embassy of the country in which, or any body approved for documentation in that country, and no more than year.
The medical report includes the patient’s personal data and information (the patient’s triple name), the medical diagnosis, the name of the scientific or commercial drug, the prescribed quantity, the treatment plan and its duration, the date of the report, the doctor’s name and specialization, the license number with the address and the stamp of the health facility.
The documents also include a copy of the medical prescription in the name of the patient, issued no more than three months ago, provided that it includes the patient’s triple name, the name of the scientific or commercial drug, the pharmaceutical form, the prescribed dose, the date of issuing the prescription, the duration of treatment, the doctor’s name and stamp and the seal of the treatment authority, and it must be authenticated by the health authority. In the country in which he received treatment, or from the country’s embassy or any authority approved for documentation in that country, and a copy of the passport or identity, and in the absence of prior permission, the customs authorities will coordinate with the Ministry to take the necessary measures based on the documents available to the traveler.